Novanta (NOVT) Cash & Equivalents (2016 - 2026)
Novanta filings provide 17 years of Cash & Equivalents readings, the most recent being $388.8 million for Q2 2026.
- On a quarterly basis, Cash & Equivalents rose 266.64% to $388.8 million in Q2 2026 year-over-year; TTM through Apr 2026 was $388.8 million, a 266.64% increase, with the full-year FY2025 number at $380.9 million, up 234.13% from a year prior.
- Cash & Equivalents hit $388.8 million in Q2 2026 for Novanta, up from $380.9 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $388.8 million in Q2 2026 to a low of $76.0 million in Q3 2023.
- Median Cash & Equivalents over the past 5 years was $98.8 million (2022), compared with a mean of $130.1 million.
- Biggest five-year swings in Cash & Equivalents: fell 24.93% in 2022 and later surged 266.64% in 2026.
- Novanta's Cash & Equivalents stood at $100.1 million in 2022, then rose by 4.94% to $105.1 million in 2023, then increased by 8.51% to $114.0 million in 2024, then skyrocketed by 234.13% to $380.9 million in 2025, then increased by 2.08% to $388.8 million in 2026.
- The last three reported values for Cash & Equivalents were $388.8 million (Q2 2026), $380.9 million (Q4 2025), and $89.2 million (Q3 2025) per Business Quant data.